337 related articles for article (PubMed ID: 28198463)
1. Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer.
Zhang J; Feng S; Su W; Bai S; Xiao L; Wang L; Thomas DG; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Beer DG; Guo YM; Chen G
Sci Rep; 2017 Feb; 7():42819. PubMed ID: 28198463
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
3. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
[TBL] [Abstract][Full Text] [Related]
4. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis.
Zeng Z; Bo H; Gong Z; Lian Y; Li X; Li X; Zhang W; Deng H; Zhou M; Peng S; Li G; Xiong W
Tumour Biol; 2016 Jan; 37(1):729-37. PubMed ID: 26245991
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
7. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer.
He J; Wu K; Guo C; Zhou JK; Pu W; Deng Y; Zuo Y; Zhao Y; Liu L; Wei YQ; Peng Y
Cell Mol Life Sci; 2018 Dec; 75(24):4667-4681. PubMed ID: 30293090
[TBL] [Abstract][Full Text] [Related]
9. FAM83A antisense RNA 1 (
Zhao H; Wang Y; Wu X; Zeng X; Lin B; Hu S; Zhang S; Li Y; Zhou Z; Zhou Y; Du C; Beer DG; Bai S; Chen G
Bioengineered; 2022 May; 13(5):13312-13327. PubMed ID: 35635086
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
11. Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis.
Zhang Y; Yu Y; Cao X; Chen P
Bioengineered; 2022 Mar; 13(3):6476-6489. PubMed ID: 35260044
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
13. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
14. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
[TBL] [Abstract][Full Text] [Related]
15. FAM83H-AS1 is associated with clinical progression and modulates cell proliferation, migration, and invasion in bladder cancer.
Shan H; Yang Y; Zhu X; Han X; Zhang P; Zhang X
J Cell Biochem; 2019 Mar; 120(3):4687-4693. PubMed ID: 30537032
[TBL] [Abstract][Full Text] [Related]
16. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.
Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y
Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer.
Wang L; He Y; Liu W; Bai S; Xiao L; Zhang J; Dhanasekaran SM; Wang Z; Kalyana-Sundaram S; Balbin OA; Shukla S; Lu Y; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Chinnaiyan AM; Beer DG; Zhang J; Chen G
Oncotarget; 2016 Mar; 7(10):11487-99. PubMed ID: 26862852
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
19. FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer.
Yang L; Cui J; Wang Y; Tan J
Biomed Pharmacother; 2019 Oct; 118():109342. PubMed ID: 31545230
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).
Bi YY; Shen G; Quan Y; Jiang W; Xu F
J Cell Physiol; 2018 Nov; 233(11):8896-8907. PubMed ID: 29870057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
